Virginia Retirement System’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Virginia Retirement System’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$220K	Buy	+50,400	New	+$224K	﹤0.01%	944

Other funds holding PGNX

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virginia Retirement System's PGNX Position: Q1 2016 in Review

Virginia Retirement System opened a new position in Progenics Pharmaceuticals Inc (PGNX) in Q1 2016: 50,400 shares worth $220K. The stake represents ﹤0.01% of the portfolio and ranks #944 among its holdings.

120 funds tracked by Wall St. Rank hold PGNX as of Q1 2016.

Virginia Retirement System held 50,400 shares of Progenics Pharmaceuticals Inc worth $220K as of Q1 2016.
Progenics Pharmaceuticals Inc was a new Virginia Retirement System position in Q1 2016.
Progenics Pharmaceuticals Inc made up ﹤0.01% of Virginia Retirement System's portfolio in Q1 2016, its #944 holding.
120 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.